One IPO and one direct listing are currently scheduled in the week ahead, although some smaller issuers may join the calendar ...

With the broader IPO calendar still muted, biopharma and life sciences issuers are cautiously testing the waters — and early trading in one name is giving the sector a modest tailwind. So far, just ...

To understand what’s holding the 2026 IPO market back and what could unlock it, Crunchbase News recently spoke with Mike ...

The primary market is set for an action-packed week with a mix of mainboard and SME IPOs opening for subscription. Investors’ attention, however, will be firmly on the mainboard space where three ...

India’s primary market will see three IPOs, including two mainboard issues and one SME offering in the upcoming week. GSP ...